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Abstract
Poisoning is a serious worldwide public health problem. Based on the World
Health Organization data in 2012, almost 190,000 people died worldwide and the
number of deaths due to poisoning in 2008 exceeded the number of deaths due to
motor vehicular crashes; also, poisoning death rate nearly tripled worldwide. The
number of patients presenting to the emergency departments with overdose had
been increased both intentionally and accidentally. All the previous facts make
toxicology an important field in emergency medicine. According to the American
Association of Poison Control Centers (AAPCC) in the United States, over 2.1
million human exposure calls are reported in 2016. Management of intoxicated
patients has a unique approach because of the challenge in diagnosis and treatment
of overdose cases. This chapter focuses on general approaches for intoxicated
patients and initial management and on how the history and physical examinations
could help physicians to have a clue about the drugs that have been abused. Patients
are most commonly poisoned via oral ingestion, but other routes could also cause
intoxication including inhalation, insufflation, cutaneous and mucous membrane
exposure, and injection.
Keywords: initial approach, physical examination, toxidromes, decontamination,
toxicology laboratory
1. Introduction
Poisoning is a serious worldwide public health problem. Based on the World
Health Organization (WHO) data in 2012, almost 190,000 people died worldwide
and the number of deaths due to poisoning in 2008 exceeded the number of deaths
due to motor vehicular crashes; also, the death rate due to poisoning nearly tripled
worldwide. The number of patients presenting to the emergency departments with
overdose had been increased both intentionally and accidentally. All the previous
facts make toxicology an important field in emergency medicine [1, 2]. According
to the American Association of Poison Control Centers (AAPCC) in the United
States, over 2.1 million human exposure calls are reported in 2016.
Management of intoxicated patients has a unique approach because of the chal-
lenge in diagnosis and treatment of overdose cases. This chapter focuses on general
approaches for intoxicated patients and initial management, explaining how the
history and physical examinations could help physicians to have a clue about the
drugs that have been abused. Patients are most commonly poisoned via oral
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ingestion, but other routes like inhalation, insufflation, cutaneous and mucous
membrane exposure, and injection could also cause intoxication.
2. General approach to toxicological cases in emergency medicine
The approach to poisoned patients must be systematic. The range of symptoms
and clinical findings in the physical examination are wide in drug poisoning
patients; initial management is focused on stabilization of life-threatening condi-
tions. The approach for the poisoned patients in emergency includes: resuscitation,
history, physical examination, and management.
Initial screening examination should be done on all patients to find out immediate
abnormal measures which need to be stabilized starting with vital signs, conscious
level and pupil size, skin temperature, pulse oximetry, and electrocardiogram.
Patients who are hemodynamically unstable must be kept in continuous cardiac
monitoring. Intravenous access should be done and the blood glucose must be
checked especially if the patients have a decreased level of consciousness.
3. Resuscitation
3.1 Airway and ventilation
The initial priorities for a poisoned patient presented to the emergency depart-
ment are: securing the airway and breathing and stabilizing the circulation. Adequate
ventilation and intubation with mechanical ventilation must be done early in the
intoxicated patients with depressed mental status, except in cases of easy reversible
causes of coma like opioid intoxication or hypoglycemia to prevent complications of
intubation like aspiration. Other indications for intubation include severe acid-base
disturbances or acute respiratory failure. In intubated patients, development of a
respiratory acidosis must be prevented by adequate ventilation; in some cases like
high-grade physiologic stimulation, the patient may need sedation and paralysis to
prevent complications such as hyperthermia, acidosis, and rhabdomyolysis.
3.2 Hypotension
Drugs cause hypotension by four major mechanisms: decreased peripheral vas-
cular resistance, decreased myocardial contractility, dysrhythmias, and depletion of
intravascular volume. First-line treatment of hypotension is IV fluid bolus (10 to
20 mL/kg); if hypotension is not responding to fluid, it may be necessary to add
vasopressors such norepinephrine. Norepinephrine is better than dopamine.
3.3 Hypertension
Elevated blood pursues caused by CNS sympathetic overactivity, increased myo-
cardial contractility or increased peripheral vascular resistance, or a combination.
The treatment of hypertension and agitated patients starts with sedatives such as
benzodiazepines; if not responding for initial treatment and there is evidence of end-
organ dysfunction, calcium-channel blocker is preferred treatment. The use of beta-
blockers is not recommended in the case of sympathetic hyperactivity because it may
cause unopposed alpha-adrenergic stimulation and intensified vasoconstriction.
Ventricular tachycardia occurs because of tricyclic antidepressant toxicity.
Sodium bicarbonate is first line therapy. Types IA (e.g., procainamide), IC, and III
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antiarrhythmic agents may worsen cardiac conduction; hence, they are not
recommended; also, using these agents could be potentially dangerous.
Magnesium sulfate can also be used in the case of drug-induced torsade de
pointes and prolonged QT intervals on ECG.
Digoxin toxicity with life-threatening tachyarrhythmias or bradyarrhythmias
should be treated with specific Fab fragments (Digibind).
3.4 Bradyarrhythmias
Treatment of bradyarrhythmias with hypotension starts with atropine and/or
temporary pacing. Calcium, glucagon, or high-dose insulin are used in the case of
calcium channel blocker or beta blocker intoxication.
3.5 Seizures
The best treatment of intoxicated patients with seizures is benzodiazepines; we
may add barbiturates if necessary. Phenytoin is not recommended to control sei-
zures in poisoned patients.
3.6 Severe hyperthermia
Elevated temperature (hyperthermia) due to drug toxicity (e.g., sympathomi-
metic overdose, serotonin syndrome, or neuroleptic malignant syndrome) must be
treated aggressively to prevent complications like rhabdomyolysis, organ failure,
and disseminated intravascular coagulation. Treatment of hyperthermia includes
active cooling like ice water immersion; if active cooling is ineffective, the patient
may need sedation, neuromuscular paralysis, and intubation.
Patients presenting with signs of opioid overdose (low Glasgow coma scale-GCS
respiratory depression, meiosis) must be given naloxone (0.1–2.0 mg I.V) as soon as
possible [3].
4. History
History of the present illness is very important and can be obtained from the
patients if they are alert and conscious; although the history following intentional
ingestion is often unreliable, which makes history taking very challenging especially
if the patients are comatose or cannot give their history, in such situations, history
can be taken from collateral information from family, friends, ambulance crew, or
medical records looking for past psychiatry illness, previous history of suicide or
drug abuse, chronic medication, etc.
History must include time, route of entry, quantity, intentional or accidental
exposure, availability of drugs at home, and if any member of the family has
chronic diseases (hypertension, diabetic, etc.) and missing tablets or any empty pill
bottles or other material was found around him [4]. It is very important to ask
specifically about the use of traditional or herbal remedies and dietary supplements.
5. Physical examination
Physical examination of poisoned patients may give clues regarding the sub-
stance which has been abused and toxidromes. Physical examination includes: gen-
eral appearance,
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• Mental status (agitated or confused)
Some drugs or substances affect the central nervous system either causing
agitation or depression.
Central nervous system depression may be caused by the following:
Anticholinergics, antidepressants, antipsychotics, lithium, cholinergic beta
blockers, clonidine, and sedative-hypnotics.
Central nervous system agitation
Sympathomimetics, anticholinergics, salicylates, central hallucinogens, drug
withdrawal states, carbon monoxide, hypoglycemic agents, and heavy metals.
• Skin (cyanosis, flashing, andphysical signs of intravenousdrug abuse (trackmarks)
Red and flushed skin occurs in the case of overdose of anticholinergic agents,
antihistamines, TCAs, atropine, scopolamine, and phenothiazines.
Pale and diaphoretic skin occurs in the case of sympathomimetics (cocaine),
cholinergic agents (organophosphates), central hallucinogens (lysergic acid
diethylamide (LSD) and phencyclidine) and salicylate toxicities.
Cyanotic skin occurs in the case of methemoglobinemia and
sulfhemoglobinemia.
• Eye examination: (pupil size reactivity lacrimation and nystagmus)
Common drugs causing miosis
• Opioids (morphine, hydromorphone, and oxycodone)
• Sedative-hypnotics (barbiturates and benzodiazepines)
• Cholinergic (nerve agents and organophosphate insecticides)
• Sympatholytic (clonidine and oxymetazoline)
• Common drugs causing mydriasis
• Sympathomimetics (cocaine and caffeine)
• Anticholinergics (atropine, scopolamine, and TCAs)
• Hallucinogens (LSD, mescaline, and psilocybin)
• Serotonin syndrome
Common drugs causing nystagmus
Barbiturates, carbamazepine, phencyclidine, phenytoin, and lithium
• Odor (garlic, bitter almonds, glue, alcohol, etc. (Table 1).
• Oropharynx hyper salivation or dryness;
• Chest: breath sound, bronchorrhea, wheezing, heart rate, and rhythm regularity;
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• Abdomen examination (bowel sound, tenderness, and rigidity);
• Limbs (tremors and fasciculation), patient’s clothing (looking for any
medications and illegal drugs) [3].
5.1 Toxidromes
The term toxidrome was coined in 1970 by Mofenson and Greensher.
Toxidromes are a group of abnormal physical examinations and abnormal vital
signs known to be present with a specific group of medications or substances. The
most common toxidromes are cholinergics, anticholinergics, sympathomimetics,
opioids, and serotonin syndrome [4, 5].
5.2 Cholinergic toxidrome
Patients with cholinergic toxidrome present with wet manifestation. SLUDGE+3
Killer B0s and DUMBELLS are simple mnemonics for the common clinical symp-
toms. Also, patients present with bradycardia, hypertension or hypotension,
tachypnoea, or bradypnea.
SLUDGE: salivation, lacrimation, urination, defecation, GI cramping, Emesis +
Killer B0s: bronchorrhea, bradycardia, and bronchospasm.
DUMBELLS: diarrhea, urination, miosis (small pupils), bradycardia, emesis,
lacrimation, lethargy, and salivation.
Most common causes: organophosphate pesticides, carbamates, some types of
mushrooms, and sarin (warfare agent) [4].
5.3 Anticholinergic toxidrome
Patients present with anticholinergic toxidrome with dry manifestation, delirium,
tachycardia, dry flushed skin, dilated pupils, hypertension, tachypnoea clonus, ele-
vated temperature, decreased bowl sounds, and urinary retention. Simple mnemon-
ics: “Hot as a Hare, Mad as a Hatter, Red as a Beet, Dry as a Bone, Blind as a Bat.”
Most common causes: antihistamines, antiparkinsonians, atropine, scopolamine,
amantadine, antipsychotics, antidepressants, muscle relaxants, and plants (jimson-
weed) [4].
5.4 Sympathomimetic toxidrome
Patients present with CNS stimulation and psychomotor agitation, elevated
blood pressure, tachycardia, dilated pupils, hyperthermia, widened pulse pressure,
tachypnoea, hyperpnea diaphoresis, and seizure in severe cases.
Most common causes: cocaine and amphetamine.
Substance Odor
Ethanol, isopropyl alcohol, chloroform, salicylates Acetone
Cyanide Bitter almonds
Organophosphates, phosphorus Garlic
Phosgene Freshly mown hay
Hydrogen sulfide Rotten eggs
Table 1.
Substances causing specific odor.
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5.5 Opioid toxidrome
The most common clinical presentation of opioid toxidrome are: coma, respira-
tory depression and meiosis, hypotension, hypothermia, bradycardia, and seizure
that may occur in propoxyphene overdose, but small pupils not always present may
present with normal size pupils such in meperidine and, propoxyphene toxicities [4].
5.6 Serotonin syndrome
Patients present with altered mental status, hypertensive, and tachycardia,
myoclonus, hyperreflexia, hyperthermia, and increase in muscle rigidity. Most
common causes: SSRI interaction or overdose of SSRIs.
MAOIs, tricyclic antidepressants, amphetamines, and fentanyl [4].
5.7 Neuromuscular malignant
Patients present with severe muscle rigidity, hyperpyrexia, altered mental sta-
tus, autonomic instability, diaphoresis, mutism, incontinence. Most common
causes: antipsychotic medication.
5.8 Sedative/hypnotic
Patients present with central nervous system depression, ataxia, dysarthria,
bradycardia, respiratory depression, hypothermia, hypotension, and bradypnea.
Most common causes are benzodiazepines and barbiturates.
5.9 Hallucinogenics
Patients present with hallucinations, perceptual distortions, depersonalization,
synaesthesia, and agitation.
Mydriasis, hyperthermia, tachycardia, hypertension, tachypnoea, and nystag-
mus. Most common causes:
phencyclidine, LSD, mescaline, psilocybin, and MDMA [“Ecstasy”].
5.10 Ethanolic
Patients present with central nervous system depression, ataxia, dysarthria, and
odor of ethanol.
5.11 Extrapyramidal
Patients present with dystonia, torticollis, muscle rigidity, choreoathetosis,
hyperreflexia, and sometimes seizures. Most common causes: risperidone, haloper-
idol, and phenothiazines.
5.12 Salicylate
Patients with salicylate toxidrome present with altered mental status, mix respi-
ratory alkalosis, metabolic acidosis, tinnitus, tachypnoea, tachycardia, diaphoresis,
nausea, vomiting, and hyperpyrexia.
Most common toxin: aspirin and oil of wintergreen (methyl salicylate).
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6. Management
6.1 Electrocardiogram (ECG)
ECG should be done on all patients who are symptomatic or who have been
exposed to cardiotoxic agents looking for the rate and conduction; ECG abnormal-
ities may help in diagnosis or may help as prognostic information. Specific attention
should be paid to QRS interval and QT interval; in the case of prolongation of QT or
QRS sodium bicarbonate infusion should be strongly considered.
6.2 Radiographic studies
Imaging examinations are not necessary in every poisoned patient but may be
useful in some situations where the toxins are radiopaque [6]. The toxins which are
radiopaque can be summarized by the mnemonic “CHIPES” (Table 2); also, “body
packers” may be seen on plain films (Figure 1). Chest x-ray is useful in the case of
noncardiogenic pulmonary edema and the acute respiratory distress syndrome due
to exposure to certain toxins.
6.3 Abdominal ultrasound
Ultrasound abdomen is not helpful in poisoned patient and the use of ultrasound
is very limited and does not appear to be a reliable method of detecting ingested
toxins [7].
6.4 Laboratory test
Blood test must be done with all intoxicated patients; especially in the case of
intentional overdose, the laboratory test should include basic lab (full cell count and
kidney function liver function and electrolytes). Acetaminophen screening is very
important in every patient presenting with altered mental status or intentional
overdose [8].
For the patients with an acid-base abnormality, serum osmolarity needs to be
checked, looking for increasing osmolar gap, which rolls out toxic alcohol ingestion.
In the case of presence of anion gap, metabolic acidosis may help and give to
physician a clue of ingestion of certain toxins like (salicylates, ethylene glycol, and
methanol or other drugs which may cause high anion gap metabolic acidosis; also
serum creatinine, glucose, ketones, and lactate should be tested to detect other
causes of the anion gap acidosis.
C Chlorinated hydrocarbons, calcium salts, and crack vials
H Heavy metals (iron, arsenic, mercury, thallium, and lead)
I Iodinated compounds (e.g., thyroxine)
P Packets of drugs (“body packers”), Play-Doh potassium salts, psychotropics (e.g.,
phenothiazines, lithium, and cyclic antidepressants
E Enteric-coated tablets (aspirin)
S Salicylates, sodium salts, and sustained-release drugs
Sustained-release preparations
Table 2.
Radiopaque toxins.
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When serum creatinine is elevated with a normal BUN, this finding is seen in the
case of isopropyl alcohol toxicity (or with diabetic ketoacidosis). Co-oximetry can
be used for rapid diagnosis of carbon monoxide toxicity and methemoglobinemia.
6.5 Toxicology screening
Toxicology screening is not necessary in case of nonintentional ingestion are
asymptomatic patient or have clinical findings that are match with the medical
history.
Drugs of abuse to opioids, benzodiazepines, cocaine metabolites, barbiturates,
tricyclic antidepressants, tetrahydrocannabinol, and phencyclidine can be detected
by using immunoassay screens in urine.
Positive and negative screens for drugs do not necessarily confirm diagnosis of
acute poisoning but require further investigations.
6.6 Limitations of toxicologic drug screening assays
• Nonspecific—because most tests can detect only typical drugs within a class:
opioids, amphetamines, benzodiazepines, cannabinoids, cocaine, barbiturates.
For example, opioid screens do not detect meperidine and amphetamine
screens do not detect methylenedioxymethamphetamine
• Drugs may be detected days to weeks after exposure. A positive test may not
mean acute poisoning
• Cross reactivity in the case of carbamazepine, cyproheptadine, and
chlorpromazine; the test can be positive for tricyclic antidepressants
• Test can be negative if tested urine was diluted.
Figure 1.
Body packers.
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7. Decontaminations
Decontamination of poisoned patient means removing the patient from the
toxin and removing the toxin from the patient, either outside the patient’s body by
gross washing or inside the body by gastrointestinal decontamination or enhanced
elimination.
7.1 Gross decontamination
Patient must be fully undressed and washed thoroughly with copious amount of
water twice regardless of how much time has elapsed since the exposure. All the
clothing must be removed and placed in plastic bags, and then the bags must be
sealed; no need to neutralize an acid with a base or a base with an acid because that
may lead to more tissue damage because the heat could be generated by this reaction.
Using any greases or creams must be avoided because they will only keep the xeno-
biotic in close contact with the skin and ultimately make its removal more difficult.
Decontamination must be done in an isolated specific area. Gross decontamina-
tion is used in chemical, biological, and radiation exposure. Healthcare providers
must wear universal precautions (gown, gloves, and eye protection) and sometimes
may need personal protective equipment.
7.2 Ocular decontamination
In the case of eye exposures to chemical substance, initially, application of a local
anesthetic agent (e.g., 0.5% tetracaine) may be needed, then copious irrigation with
crystalloid solution. Lid retraction facilitates the irrigation. Alkalis cause more
injury than acids because of deep tissue penetration via liquefaction so may need
prolonged irrigation (1 to 2 hours). pH of conjunctival sac should be tested and
irrigation should be continued until pH is <7.4.
7.3 Gastrointestinal decontamination
There are multiple methods used for gastrointestinal decontamination including:
• Emesis
Induced vomiting by ipecac syrup can decrease absorption and was used in
the past but now is rarely indicated because there is no evidence supporting its
effectiveness in reducing toxin absorption. It may also increase the risk of
complications. Syrup ipecac may be considered in conscious, alert patients with
ingestion of a potential number of toxic drugs and present in a very short time after
ingestion (<1 hour).
Contradictions:
• Unprotected airway
• Corrosive/hydrocarbon ingestion
• Unstable patient status (hypotensive-seizure) [9].
• Gastric lavage
9
General Approach to Poisoned Patient
DOI: http://dx.doi.org/10.5772/intechopen.84681
Gastric lavage is an intervention widely used to remove the ingested toxin drugs
from the stomach by an orogastric tube. Because of the absence of published
evidence that shows that orogastric lavage may change the outcome, now orogastric
lavage is rarely indicated. It may be considered in the case of recent (<1 hour)
ingestion of life-threatening amount of a toxin for which there is no effective
treatment once absorbed.
Contraindications:
• Corrosive/hydrocarbon ingestion
• Supportive care/antidote likely to lead to recovery
• Unprotected airway
• Unstable, requiring further resuscitation (hypotension and seizures).
Complications:
• Aspiration pneumonia
• Water intoxication
• Hypothermia
• Laryngospasm
• Mechanical injury to gastrointestinal tract.
• Activated charcoal:
Activated charcoal is a super-heating carbonaceous material. Activated charcoal
works by reducing the absorption of a substance in the gastrointestinal lumen but it
is not effective in metal, alcohols, corrosives, and lithium. The most effective action
can be achieved when activated charcoal is given within the first hour of ingestion.
In the case of intubated patients, activated charcoal may be administered via an
orogastric or nasogastric tube.
Dose:
• Children 1 to 12 years of age: 25 to 50 g or 0.5 to 1.0 g/kg (maximum dose 50 g)
• Adults: 25 to 100 g (with 50 g representing the usual adult dose).
Contraindications:
Substances not adsorbed by activated charcoal.
• Unprotected airway
• Corrosive ingestion
• Upper gastrointestinal perforation.
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Complications:
• Vomiting
• Aspiration of the activated charcoal
• Reduce absorption of orally administered antidotes [10]
• Whole-bowel irrigation:
Whole-bowel irrigation is a mechanical cleansing of the whole gastrointestinal
track reducing toxin absorption. The whole-bowel irrigation can be done by Poly-
ethylene glycol solution. Polyethylene glycol is an osmotically balanced electrolyte
solution; polyethylene glycol can be given orally to cooperative, awake patients.
Patient positioning (head up 30°) reduces the risk of pulmonary aspiration; during
whole-bowel irrigation also bowel sounds must be present. Clear rectal effluent and
imaging shows the absence of foreign bodies considered as endpoint of whole-
bowel irrigation treatment.
Indication:
• Iron ingestion >60 mg/kg with opacities on abdominal radiograph
• Life-threatening ingestion of diltiazem or verapamil
• Body packers or stuffers
• Slow-release potassium ingestion
• Lead ingestion (including paint flakes containing lead)
• Symptomatic arsenic trioxide ingestion
• Life-threatening ingestions of lithium
• Contraindications
• Unprotected airway.
Gastrointestinal obstruction absent bowel sound or perforation [11].
Recurrent, unstoppable vomiting.
Complications:
• Nausea and vomiting
• Pulmonary aspiration
• Vomiting, bloating, and rectal irritation.
8. Enhanced elimination
Enhanced elimination is a method used to increase the rate of toxic removal
from the body so as to reduce the severity and duration of clinical intoxication.
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Enhanced elimination methods are not routinely used in poisoned patients. The
indications for enhanced elimination include: [4].
• Severe toxicity
• Poor outcome despite supportive care/antidote
• Slow endogenous rate of elimination.
There are different techniques to enhance elimination:
Multiple dose activated charcoal (MDAC).
MDAC is defined as at least two sequential doses of activated charcoal [12].
Multidose activated charcoal can be given via orogastric or nasogastric tube to
intubated patients.
Mechanism of action:
• Prevents ongoing absorption of toxin that persists in the GI tract (modified-
release preparation)
• Enhances elimination in the post absorptive phase by delayed enterohepatic
recirculation or enteroenteric recirculation (“gut dialysis”).
Indications:
Ingestion of a life-threatening amount of carbamazepine, dapsone,
phenobarbital, quinine, salicylates, or theophylline.
Ingestion of a life-threatening amount of another toxin that undergoes
enterohepatic or enteroenteric recirculation and that is adsorbed to activated
charcoal.
Ingestion of a significant amount of any slowly released toxin.
Contraindications:
• Unprotected airway
• Bowel obstruction.
Complications:
• Vomiting
• Pulmonary aspiration
• Constipation
• Bowel obstruction or perforation.
Dose: no optimal dose of MDAC has been established. But the acceptable regi-
men of 50 g is administered every 4 hours, or 25 g every 2 hours. Study on volunteer
found no difference in effectiveness of larger doses spread out over time compared
to smaller, more frequent dose [13].
• Urinary alkalinization
12
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Urine alkalinization is a treatment regimen which enhances the elimination of
toxins by administration of intravenous sodium bicarbonate to produce urine with
pH > or = 7.5.
Alkaline urine acts on ionization of acidotic toxins within renal tubules, stopping
resorption of the ionized drug back across the renal tubular epithelium and
enhancing elimination through the urine [14].
Characteristics of drugs which respond to urinary alkalinization are [15].
• Eliminated predominantly unchanged by the kidney
• Distributed primarily in the extracellular fluid compartment
• Minimal protein-bound
• Weak acids (3.0 to 7.5).
Urinary alkalinization for poisoned patients can be done by the following steps:
• Correct hypokalemia
• Start with 1 to 2 mEq/kg IV sodium bicarbonate bolus
• Infuse 100 mEq of sodium bicarbonate mixed with 1 L of D5W at 250 mL/h
• Potassium chloride (20 mEq) can be added to maintain normokalemia
• Monitoring serum potassium and bicarbonate level every 2 to 4 hours to
prevent hypokalaemia
• Urine pH should be checked regularly, keeping urine pH between 7.5 and 8.5.
Indications:
• Moderate to severe salicylate toxicity
• Phenobarbital severe toxicity
• Chlorophenoxy herbicide severe toxicity
• Chlorpropamide severe toxicity.
Contraindications:
• Pre-existing fluid overload
• Renal impairment
• Uncorrected hypokalaemia.
Complications:
• Hypokalaemia
13
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• Volume overload
• Alkalemia.
• Urinary acidification (urine pH below 5.5) with ammonium chloride or
ascorbic acid was used in the past to treat toxicity of weak bases such as
amphetamines, quinidine, or phencyclidine. However, this practice is not used
now because of lack of evidence of efficacy and complications such as
iatrogenic toxicity (from severe academia) and rhabdomyolysis may occur.
• Extracorporeal elimination includes hemodialysis, hemoperfusion, and
continuous renal replacement therapies, this method has limited indications in
intoxicated patients, extracorporeal elimination need critical care setting also
this procure are expensive and invasive, are not always available
extracorporeal elimination were used in less than 0.1% of cases reported to U.S.
poison control centers in 2010 [16]. The toxins need to have a number of
criteria to be effectively removed by extracorporeal elimination [17]:
• low volume of distribution (<1.0 L/kg),
• low molecular weight (<500 Da), relatively
• low protein binding
• low endogenous clearance.
Indications:
Life-threatening toxicity of
• Lithium
• Metformin lactic acidosis
• Phenobarbital
• Salicylates
• Valproic acid
• Methanol/ethylene glycol
• Potassium salts
• Theophylline.
Contraindications:
• Hemodynamic instability
• Active hemorrhage
• Severe thrombocytopenia
• Sever coagulopathy
14
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9. Extracorporeal membrane oxygenation (ECMO)
ECMO: extracorporeal technique used when the patients are critically ill and
they cannot provide an adequate amount of gas exchange or perfusion to sustain.
This technique may be used in the case of severe and massive overdose especially
cardiotoxic drugs (beta blockers, calcium channel blocker) [18].
10. Antidotes
Although supportive care is the main treatment of most poisoned patients, there
are cases in which administration of a specific antidote is potentially life-saving.
Antidote is a substance that can prevent further poisoning from specific substances.
Table 3 shows the most common antidote used in the emergency department (see
Table 1) [4].
Toxin Antidote
Acetaminophen N-acetylcysteine 150 mg/kg dextrose IV over 15–60 min, then 50 mg/kg
NAC IV over 4 hrs. Then 100 mg /kg NAC IV over 16 hrs.
Cholinergic
(organophosphates,
carbamates)
Atropine 1-2 mg every 2–3 min, until there is drying of secretions,
pralidoxime (2-PAM) 70 mg/kg IV, then infusion at 500 mg/hour
Anticholinesterases Physostigmine 0.5–1 mg IV as a slow push over 5 min and repeated
every 10 min
Benzodiazepines Flumazenil 0.2 mg repeated; max dose: 2 mg
β-Blockers Glucagon 3–10 mg
Calcium channel blockers Calcium gluconate 10% 10–30 mL IV
Cyanide Amyl nitrite, sodium thiosulfate, sodium nitrite (3% solution), and
Vitamin B12
Digoxin Digoxin Fab 5–10 vials
Isoniazid Pyridoxine (vitamin B6) 70 mg/kg IV (maximum 5 g)
Methanol, ethylene glycol Ethanol loading: 8 ml/kg of 10% ethanol then 1–2 ml/kg/hour of 10%
ethanol; fomepizole Loading: 15 mg/kg in 100 ml IV over 30 min.
Maintenance: 10 mg/kg IV over 30 min every 12 hours for 48 hr.
Narcotics Naloxone 0.1–0.4 mg, may be repeated
Tricyclic antidepressants Sodium bicarbonate 1–2 mEq/kg IV bolus followed by 2 mEq/kg per h
IV infusion
Iron Deferoxamine IV infusion dose of 15 mg/kg/hour
Methaemoglobinaemia Methylene blue 1–2 mg/kg (0.1–0.2 ml/kg of 1% solution) IV slowly
over 5 min
Local anesthetics Intravenous lipid emulsion 1–1.5 ml/kg 20% IV bolus over 1 min, repeat
bolus at 3–5 min, then infuse 0.25 ml/kg/min
Wernicke’s syndrome, wet
beriberi
100 mg IV
Insulin, oral hypoglycemics Dextrose (glucose) 1 g/kg IV
Table 3.
Antidote.
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11. Disposition
If the patient has persistent and toxic effects, the patient will require prolonged
care course. Admission is indicated for completing his treatment and observation; in
the case of severe toxicity, the patient may need admission to intensive care unit.
In the case of mild toxicity or asymptomatic patient, a 6-hour observation period
is sufficient to exclude the development of serious toxicity.
A number of toxins have delayed onset clinical toxicity, for example (but not
limited to): modified-release preparations of calcium channel antagonists, selective
norepinephrine reuptake inhibitors (tramadol and venlafaxine), and newer anti-
psychotics (amisulpride); this means that the duration of observation should be
longer than usual.
The decision to admit a patient with a toxic exposure to an intensive care setting
should be based upon clinical criteria that relate to the stability of the airway,
respiratory system, cardiovascular system, and the patient’s level of consciousness.
A retrospective study which was done in more than 200 patients with drug
overdoses shows that clinical assessment in the emergency department could reli-
ably find out patients who are at high risk for complications and need intensive care
unit admission [19].
Based on the following clinical criteria: if the patient has one of any of the
following clinical criteria, the patient may need admission to intensive care unit:
• PaCO2 > 45 mmHg
• Intubated patient
• Seizures post-ingestion
• Unresponsiveness to verbal stimuli
• Abnormal cardiac rhythm (nonsinus)
• Atrioventricular block (Second- or third-degree)
• Systolic blood pressure below 80 mmHg
• QRS duration ≥0.12 seconds.
12. Conclusion
The first step in the approach to intoxicated patient should start with stabiliza-
tion measures including protected airway and adequate ventilation and circulation
and control of the convulsion.
History in poisoning cases could be difficult; especially in self-harm poisoning or
comatose patients, the physician must use collateral information from friends,
family, prehospital personal and medical records.
Always ask, especially about the use of over-the-counter drugs and traditional or
herbal preparations.
Physical examination may help to find the toxidrome and complication of
toxins; physical examination should include all systems.
Focused laboratory test helps physicians to understand the severity of toxicity
and suspected toxin and guides in management, making sure the drug level is sent
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at proper time not so early or late to avoid wrong interpretation; urine or blood
toxicology screen assays have limited value in the case of acute over dose. Most of
poisoned patients only supportive care with decontamination will be sufficient for
them, but antidotes same times is the cornerstone of the treatment.
In the end, remember all the time “treat the patient, not the poison.”
Author details
Ehab Said Aki* and Jalal Alessai
Emergency Department, Hamad Medical Corporation, Doha, Qatar
*Address all correspondence to: akiehab2004@gmail.com
©2019 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
17
General Approach to Poisoned Patient
DOI: http://dx.doi.org/10.5772/intechopen.84681
References
[1]Warner M, Chen LH, Diane M,
Makuc RN, Anderson AM. Miniño.
Drug poisoning deaths in the United
States, 1980–2008. NCHS Data Brief.
2011;81:1-8
[2] Liu Q, Zhou L, Zheng N, et al.
Poisoning deaths in China: Type and
prevalence detected at the Tongji
Forensic Medical Center in Hubei.
Forensic Science International. 2009;
193:88
[3] Erickson TB, Thompson TM, Lu JJ.
The approach to the patient with an
unknown overdose. Emergency
Medicine Clinics of North America.
2007;25:249
[4] Shaun G. General management of
poisoned patients. In: Tintinalli JE, et al.,
eds. Tintinalli’s Emergency Medicine
Comprehensive Study Guide. 8th ed.
New York, NY: McGraw-Hill; 2016
[5]Mofenson HC, Greensher J. The
nontoxic ingestion. Paediatric Clinics of
North America. 1970;17(3):583-590
[6] Savitt DL, Hawkins HH, Roberts JR.
The radiopacity of ingested medications.
Annals of Emergency Medicine. 1987;
16(3):331-339
[7] Taftachi F, Sanaei-Zadeh H, Zamani
N, Emamhadi M. The role of ultrasound
in the visualization of the ingested
medications in acute poisoning—A
literature review. European Review for
Medical and Pharmacological Sciences.
2012;16(15):2175-2177
[8] Sporer KA, Khayam-Bashi H.
Acetaminophen andsalicylate serum
levels in patients with suicidal ingestion
or altered mental status. The American
Journal of Emergency Medicine. 1996;
14(5):443-446
[9]Manoguerra AS, Cobaugh DJ.
Guidelines for the Management of
Poisoning Consensus Panel: Guideline
on the use of ipecac syrup in the out-of-
hospital management of ingested
poisons. Clinical Toxicology
(Philadelphia). 2005;43:1
[10] Adams BK, Mann MD, Aboo A,
et al. Prolonged gastric emptying half-
time and gastric hypomotility after drug
overdose. The American Journal of
Emergency Medicine. 2004;22:548
[11] Lheureux P, Tenenbein M. Position
paper: Whole bowel irrigation. Journal
of Toxicology. Clinical Toxicology.
2004;42(6):843
[12]Vale JA, Krenzelok EP, BarcelouxGD.
Position statement andpractice guidelines
on the use of multi-dose activated
charcoal in the treatment of acute
poisoning. American Academy of Clinical
Toxicology: European Association of
Poisons Centres and Clinical
Toxicologists. Journal of Toxicology.
Clinical Toxicology. 1999;37:731-751
[13] Ilkhanipour K, Yealy DM, Krenzelok
EP. The comparative efficacy of various
multiple-dose activated charcoal
regimens. The American Journal of
Emergency Medicine. 1992;10(4):298
[14] Proudfoot AT, Krenzelok EP, Vale
JA. Position paper on urine
alkalinization. Journal of Toxicology:
Clinical Toxicology. 2004;42:1-26
[15]Garrettson LK, Geller RJ. Acid and
alkaline diuresis. When are they of value
in the treatment of poisoning? Drug
Safety. 1990;5:220
[16] Bronstein AC, Spyker DA, Cantilena
LR Jr, et al. Annual report of the
American Association of Poison Control
Centers' National Poison Data System
(NPDS): 28th annual report. Clinical
Toxicology (Philadelphia). 2010, 2011;
49:910-941
18
Poisoning in the Modern World ‐ New Tricks for an Old Dog?
[17] Fertel BS, Nelson LS, Goldfarb DS.
Extracorporeal removal techniques for
the poisoned patient: A review for the
intensivist. Journal of Intensive Care
Medicine. 2010;25:139-148
[18] Rona R, Cortinovis B, Marcolin R,
et al. Extra-corporeal life support for
near-fatal multi-drug intoxication: A
case report. Journal of Medical Case
Reports. 2011;5:231. DOI: 10.1186/
1752-1947-5-231
[19] Brett AS, Rothschild N, Gray R,
et al. Predicting the clinical course in
intentional drug overdose. Implications
for use of the intensive care unit.
Archives of Internal Medicine. 1987;
147(1):133-137
19
General Approach to Poisoned Patient
DOI: http://dx.doi.org/10.5772/intechopen.84681
